- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Eli Lilly and Co.
Lilly extends research pact with India firm
December 1, 2009
IBJ StaffJubilant Organosys Ltd. and Indianapolis-based Eli Lilly and Co. extended their collaboration, which began in 2005, by five
years.
MoreLilly's Cymbalta wins new approval for anxiety disorder
November 30, 2009
J.K. WallFDA action should boost sales of the Eli Lilly and Co. drug, which were already on pace to top $3 billion this year.
MoreLilly stock droops after rival claims faster-acting impotence pill
November 18, 2009
IBJ StaffCalifornia-based Vivus claims its drug acts in 30 minutes, compared with about 2 hours for Lilly's Cialis.
MoreLilly to pay Utah $24 million to settle Zyprexa suit
November 11, 2009
Eli Lilly and Co. has agreed to pay Utah $24 million to settle a lawsuit claiming the company improperly marketed the antipsychotic
drug Zyprexa.
MoreLilly, WellPoint CEOs pin hopes on Senate
November 11, 2009
J.K. WallDrugmaker and health insurer bemoan aspects of House health reform bill and hope Senate crafts more industry-friendly bill.
MoreLilly reducing sales force by 191 as part of larger restructuring
November 2, 2009
Eli Lilly and Co. has notified the state that it plans to eliminate 191 sales jobs as part of a company-wide restructuring
announced
in September
that ultimately will result in 5,500 job cuts by the end of 2011.
MoreTechPoint to focus on IT firms specializing in medical, life sciences sectors
October 31, 2009
Chris O'MalleyLong tracking the emergence of information technology firms involved in the health and life sciences sector, the state’s
IT trade group, TechPoint, is undergoing a mitosis of sorts to help fuel the trend. It has created Advancing
Life Science & Health Care Information Technology, or ALHIT, which will focus on growing this subset of the IT realm.
MoreLilly opens new biotech center in San Diego
October 29, 2009
J.K. WallLilly is opening the San Diego biotech center a year after launching a biotech R&D center in Indianapolis.
MoreLilly to move 1,000 from Faris campus
October 26, 2009
J.K. WallAs it shrinks its work force, Indianapolis-based pharmaceutical firm Eli Lilly and Co. will move more than 1,000 employees
to its corporate
center
by mid-2010.
MoreLilly needs to sell more Effient before Zyprexa loses patent protection
October 24, 2009
J.K. WallSales of Eli Lilly and Co.’s newest drug were an afterthought during its Oct. 21 report on third-quarter earnings. The
blood thinner Effient totaled up $22.6 million in sales—a mere 0.4 percent of Lilly’s total for
the quarter.
MoreLilly settles Zyprexa case with S. Carolina for $45M
October 23, 2009
IBJ Staff and Associated PressSouth Carolina Attorney General Henry McMaster said Friday that the state has reached a $45 million settlement with drug maker
Eli Lilly and Co. over the company's marketing of an anti-psychotic drug.
MoreEli Lilly CEO banking on new drug pipeline
October 22, 2009
Associated PressCEO John Lechleiter says Lilly's pipeline has helped it rebound from significant patent losses three times during his 30-year
career at the company. He's betting there will be a fourth.
MoreLilly, GE announce cancer diagnostic breakthrough
October 21, 2009
J.K. WallEli Lilly and Co. and General Electric Co. say they've made a breakthrough in cancer research that could help Lilly cut the
size and cost of its clinical trials.
MoreUncertainty over drug pipeline sends Lilly shares down
October 21, 2009
J.K. WallFor the first time publicly, Eli Lilly and Co. officials admitted the obvious: Their pipeline products
aren't likely to offset the revenue the company will lose after its two bestsellers, Zyprexa and Cymbalta, lose patent exclusivity.
MoreLilly reports $942 million profit in third quarter
October 21, 2009
J.K. WallExcluding special items, Eli Lilly and Co.'s earnings per share spike 22 percent on the strength of Alimta, Cymbalta and Humalog
sales. Lilly's revenue rose 7 percent in the quarter over the same period of 2008,
to $5.56 billion.
MoreMedco plans to compare Plavix, Effient in study
October 20, 2009
IBJ Staff and Associated PressMedco Health Solutions Inc. said Tuesday it will compare the blood thinner Plavix, the world's second-best selling drug, with
Effient, a potential blockbuster drug sold by Indianapolis-based Eli Lilly and Co.
MoreGerman company to buy Eli Lilly's Lafayette plant
October 17, 2009
J.K. WallEli Lilly and Co. will sell its manufacturing plant in Lafayette to a German company in its first major move toward reducing
its work force by 5,500 employees and cutting its operating expenses by $1 billion.
MoreLilly to pay Idaho $13M in drug settlement
October 14, 2009
IBJ Staff and Associated PressIdaho is getting $13 million as part of a settlement reached with Indianapolis-based Eli Lilly and Co. over its marketing
of
anti-psychotic drug Zyprexa.
MoreLilly to sell Lafayette plant to German firm
October 14, 2009
J.K. WallNearly 700 workers will be offered severance, new jobs
MoreBaucus health reform bill would stick Indiana companies with fees
October 10, 2009
IBJ StaffThe health reform bill sponsored by U.S. Sen. Max Baucus, D-Mont., would help pay for expanded health insurance coverage
by levying fees of $13 billion a year on the health care industry. The fees would deliver a hefty bill to just
about all of Indiana’s major health care companies. But how they’re reacting to the fees is all over the map.
MoreLilly settles Zyprexa suit with S. Carolina
October 7, 2009
IBJ StaffEli Lilly and Co. has agreed to settle the State of South Carolina's lawsuit that claimed Lilly improperly marketed the antipsychotic
drug Zyprexa, according to Bloomberg News.
MoreLilly's win in Evista patent case crucial, analyst says
September 24, 2009
Scott OlsonA decision by a federal judge in Indianapolis to turn back a patent challenge to Eli Lilly and Co.'s Evista marks a major
victory for the company, says an analyst who closely follows the pharmaceutical industry.
MoreJudge upholds Lilly's Evista patent
September 24, 2009
J.K. WallA federal judge in Indianapolis turned back a patent challenge to Eli Lilly and Co.’s drug Evista, the company announced
late yesterday.
MoreLilly agrees to settle more state Zyprexa suits
September 22, 2009
Eli Lilly and Co. has agreed to confidential terms to settle lawsuits brought by seven states alleging the company illegally
marketed bestselling antipsychotic drug Zyprexa, Bloomberg News reported today.
MoreLilly revises playbook in effort to score more 'touchdowns'
September 19, 2009
J.K. WallThe drugmaker has successfully moved experimental drugs into position to win approval by regulators. But only once in the
last four years has a new drug actually made it to market—the industry’s equivalent of getting
across the goal line.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
It's also across the street from Fogo de Chao and Morton's....
Yep, the haters are trying to make good news bad. I guess it is hard to get people to believe the series is dying when they are gaining new sponsors.
David Copperfield! I remember watching his specials on TV when I was little.
Don't forget this is next to an MMA gym, a pawn shop, and some abandoned spaces.
Good project for Zionsville - A group who has owned the property for many years has waited and worked patiently to bring highest and best use development to a major corridor, and mix that in with the great downtown you have. Win Win. All the Best to Pittman Partners and Zionsville.